Sponsor or institution

Clinical trials and research at Taiho Oncology, Inc.

• 7Clinical trials
• 32Countries

Newest trials

All recruiting trials (7)

• ARC-02 with Rituximab for B-cell non-Hodgkin lymphomas

  This study tests ARC-02, together with Rituximab, to see if the treatment is safe and shows early signs of activity in people with B-cell non-Hodgkin lymphomas who have already tried multiple therapies.

  Recruiting at 3 sites Phase 1 Taiho Oncology, Inc. · Los Angeles, California and 27 other locations · NCT07691606

• Zipalertinib vs placebo after surgery for uncommon EGFR-mutant NSCLC

  This study tests whether zipalertinib can help people with early-stage, surgically removed NSCLC that has uncommon EGFR mutations-by comparing it to placebo.

  Recruiting at 108 sites Phase 3 Taiho Oncology, Inc. · Anchorage, Alaska and 252 other locations · NCT07128199

• Evaluating zipalertinib for advanced lung cancer with specific EGFR mutations

  This study is testing a new drug called zipalertinib to see if it can help people with advanced lung cancer that has specific genetic mutations and who have few other treatment options.

  Recruiting at 69 sites Phase 2 Taiho Oncology, Inc. · Birmingham, Alabama and 79 other locations · NCT05967689

• Futibatinib treatment for advanced cholangiocarcinoma with FGFR2 gene changes

  This study is testing if two different doses of a new drug called futibatinib can help people with advanced bile duct cancer that has specific gene changes feel better after other treatments.

  Recruiting at 10 sites Phase 2 Taiho Oncology, Inc. · La Jolla, California and 64 other locations · NCT05727176

• Evaluating a new oral cancer treatment for patients with liver issues

  This study is testing a new oral cancer treatment for patients with liver problems to see if it is safe and effective for those who can't use standard therapies.

  Recruiting at 17 sites Phase 1 Taiho Oncology, Inc. · Houston, Texas and 21 other locations · NCT04953910

• Evaluating a new oral cancer treatment for patients with kidney issues

  This study is testing a new oral cancer treatment for adults with kidney issues to see if it is safe and effective for those with certain types of cancer.

  Recruiting at 16 sites Phase 1 Taiho Oncology, Inc. · Houston, Texas and 20 other locations · NCT04953897

• Testing a new oral medication for blood cancers

  This study is testing a new oral medication for blood cancers to see if it works better than the standard treatment for patients with myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia.

  Recruiting at 65 sites Phase 2/3 Taiho Oncology, Inc. · Los Angeles, California and 72 other locations · NCT04256317

Quick answers

How many clinical trials run by Taiho Oncology, Inc. are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 32 countries. The most sites are in Spain (7 trials), United States (7 trials), Poland (6 trials), Italy (5 trials), Australia (4 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 3, Phase 2: 2, Phase 2/3: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →